GLASS HOUSE COUNSELING AGENCY LLC SOS Verified
1800 E. SAHARA AVE SUITE 202, LAS VEGAS, NV 89104
NPI Number
1649576471
Practice location · View on Google Maps
SOS Verification: Verified
Entity Name: GLASS HOUSE COUNSELING AGENCY, LLC
Entity Number: E0637052010-0
Entity Type: Domestic Limited-Liability Company
Entity Status: Active
Formation Date: 2010-12-23
Status Changed: 2017-10-03
Name Match: 95%
Registered Agent
Name: Registered Agents Inc * (N)
Type: Commercial Registered Agent
Address: 732 S 6TH ST, STE R, Las Vegas, NV, 89101
Officers / Principals
| Title | Name | Address | Status |
|---|---|---|---|
| Manager | MARIE WESTMORELAND | 3769 Warmbreeze Way, Las Vegas, NV | Active |
Total Medicaid Payments
$18,389
-99% vs specialty average
Patients Seen
105
Total Claims
342
$ Per Patient
$175
Specialty avg: $227
Specialty Rank
#350 of 392
Community/Behavioral Health providers in Nevada
Peer Average
$1,269,573
Average total for Community/Behavioral Health
Claims per Patient
3.3
Average visits / services per person
Payments by Year
How much Medicaid paid this provider each year. Large jumps can indicate changes in practice volume or billing patterns.
| Year | Total Paid | % of Max |
|---|---|---|
| 2018 | $1,700 | |
| 2019 | $5,657 | |
| 2022 | $11,031 |
Procedure Code Breakdown
The specific medical services this provider billed Medicaid for. Each HCPCS/CPT code represents a different type of visit, test, or treatment.
| HCPCS Code | Description | Claims | Paid | % of Total | Avg per Claim |
|---|---|---|---|---|---|
| 90837 | Individual therapy session (60 minutes) | 139 | $11,031 | 60.0% | $79 |
| 90853 | Group therapy session | 141 | $4,179 | 22.7% | $30 |
| 90834 | Individual therapy session (45 minutes) | 62 | $3,179 | 17.3% | $51 |
About This Data
This data comes from the HHS Medicaid Provider Spending dataset (opendata.hhs.gov). It shows payments made through Nevada Medicaid from 2018–2024. High payments do not mean a provider is doing anything wrong — some specialties naturally cost more, and busy providers see more patients. But unusually high numbers compared to peers can be worth a closer look.